Williamstown, MA -- (SBWIRE) -- 05/01/2012 -- A complete global analysis of the prospects for markets and companies in this dynamic industry sector
Features and benefits of this thoroughly-researched and highly-regarded management report:
High quality: Original research, novel 5-year market forecasts and informed commentary from our experienced editors are allied with unrivalled primary source data
Global coverage: Covers leading economies as well as key emerging markets such as Russia and Brazil
Issue driven: Understand the latest company, product, and regulatory developments
Company Focus: Who's working with whom? Who's suing whom? Who's up, who's down? Detailed and frank appraisals of 27 leading companies in the field
Flexible formats: Available in pdf or print with Espicom Interactive access included in the price. Cost-effective distribution licences can ensure you get the best from your investment
Easily understand the threats and opportunities that are shaping this rapidly evolving sector!
View Full Report Details and Table of Contents
Industry consolidation, new market opportunities, the latest on biosimilars plus much, much more! This leading report, now in its 10th year of publication, draws on primary research with companies, statistics offices, health ministries and trade associations worldwide and provides standard, comparative data and discussion on key issues. This extensive data set is interpreted and evaluated by the editors to provide a complete and compelling review of the whole sector.
Key facts, issues and questions
What branded companies are taking an interest in generics - we identify and assess the latest developments
What has Teva been up to in Japan in 2011?
Biosimilars get ever closer - latest regulatory data update
Which Mediterranean country might expect a generic sector average growth rate of 14.8% a year to 2016?
The political, regulatory and funding background in key markets
What pricing and production issue must generic companies overcome in Brazil?
Low market penetration of generics makes Italy an attractive proposition for generic manufacturers but what are the challenges?
How generic companies are faring in the recession
Who is involved in the latest legal challenges and litigation?
The generic sector is fast growing, driven by demand for cost-effective medicines and new availability of high value products
World Generics per capita spend (US$) forecast to 2016
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Pharmaceuticals research reports at Fast Market Research
You may also be interested in these related reports:
- CNS Generic Drugs: Prospects and Opportunities to 2012
- All Change in the US Pharma Market?
- Global Pharmaceutical Survey 2012-2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry
- The World Generic Market Report 2011
- Men's Health Therapeutics Market to 2017 - Availability of Generic Sildenafil from 2012 to Restrain Market Growth
- Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry
- Cardiovascular Generic Drugs: Prospects and Opportunities to 2012